Chief Physician, MD, PI. Graduated from Central South University, and received professional and systematic training in radiotherapy at well-known domestic oncology hospitals in Chengdu, Beijing, and Guangzhou.

Specialties: Head and neck tumors (including brain, nasopharynx, oropharynx, hypopharynx, larynx, parotid gland, sinuses, esophagus, etc.); breast cancer; digestive system tumors (including liver cancer, pancreatic cancer, gastric cancer, rectal cancer, pancreatic head cancer, gallbladder cancer, etc.); urogenital tumors (including cervical cancer, prostate cancer, endometrial cancer, kidney cancer); radiation therapy for pediatric tumors, soft tissue sarcomas, chest tumors, and rare tumors; integration of multimodal advanced radiotherapy techniques for the treatment of difficult and complex intractable tumors; extensive experience in the prevention, diagnosis, and treatment of complications from tumor chemoradiotherapy.

The mechanism of occurrence and development of malignant tumors, as well as the radioimmunotherapy for complex and refractory tumors such as recurrence and metastasis (including spatial fractionation radiotherapy, low-dose radiotherapy, targeted radiotherapy with draining lymph node preservation, simultaneous boost stereotactic radiotherapy, three-dimensional brachytherapy, etc.).

I. Member of the Second Committee of the Palliative Care Specialty Committee of the Chinese Anti-Cancer Association

II. Member of the Third Committee of the Radiotherapy Equipment Technology Branch of the China Medical Equipment Association

III. Standing Committee Member of the Seventh Committee of the Radiation Oncology Branch of the Hainan Provincial Medical Association

IV. Member of the Lung Cancer Professional Committee of the Hainan Provincial Cancer Prevention and Control Association

V. Vice Chairman of the Multidisciplinary Treatment (MDT) Professional Committee of the Hainan Provincial Cancer Prevention and Treatment Association

VI. Executive member of the Fertility Preservation Professional Committee of the Hainan Provincial Maternal and Child Health Care Association

VII. Member of the First Committee of the Integrative Rehabilitation Specialty for Nasopharyngeal Cancer, Chinese Anti-Cancer Association

VIII. Member of the Expert Committee for the Special Skills Training Program in Precision Radiotherapy for Tumors (in the direction of target delineation) at the Talent Exchange Service Center of the National Health Commission

IX. Member of the Expert Committee of the Medical Quality Control Center for Radiotherapy Specialty in Hainan Province (June 2023 - December 2024)

I. Proteomics analysis of G protein-coupled receptor kinase 4-inhibited cellular growth of HEK293 cells. J Proteomics. 2019;  207:103445.

II. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database, Clin Transl Oncol, 2021,7.

III. Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma, Int J Gen Med, 2021, 14: 9247-9260.

IV. Myoepithelial carcinoma of major salivary glands: Analysis of population-based clinicopathologic and prognostic features, Translational oncology 20 (2022) 101410.